CYBB and neoplasm: When NOX2-ROS production was inhibited by idelalisib, a phosphatidylinositol-4,5-bisphosphate-3 kinase-δ (PI3Kδ) inhibitor, NK cells were rescued and tumor clearance improved in leukemia models [93].